Centessa Pharmaceuticals Appoints Stephen Kanes As CMO

(RTTNews) - Centessa Pharmaceuticals Plc (CNTA) said on Wednesday that it has appointed Stephen Kanes as its Chief Medical Officer. Kanes is a neuropsychiatrist with a career in neuroscience, clinical psychiatry, and neuroscience drug development spanning over three decades. 

Most recently, Kanes was CEO of EmbarkNeuro, a neuroscience-focused biotech firm. Earlier, he was Executive Director in Clinical Development in the Inflammation, Neuroscience, and Respiratory therapeutic areas at AstraZeneca and a faculty member of the Department of Psychiatry, University of Pennsylvania.